Czy chorzy na cukrzycę są bardziej ryzykownymi kierowcami niż inni ludzie?

1. Mawby M.: Time for law to catch up with life (editorial). Diabetes Care 1997; 20: 1640. 2. Otto-Buczkowska E.: Medyczne dylematy przy udzielaniu zgody na przydział licencji kierowcy. Pol Merkuriusz Lek. 2002; 13, 74: 172. 3. Otto-Buczkowska E.: Licencja kierowcy dla chorego na cukrzycę – warunki i ograniczenia. Pol. Merk. Lek., 2002; 13, 78: 351-353. 4. Otto-Buczkowska E., Dworzecki T.: Chosen life aspects of diabetic patients. In Trends in Diabetes Mellitus Research. Ford AM. (red).: Nova Science Publishers 2005. 5. Akiyama T., et al.: Resumption of Driving after Life-Threatening Ventricular Tachyarrhythmia. N. Engl. J. Med., 2001; 345: 391-397. 6. Buttner A., et al.: Sudden natural death „at the wheel”: a retrospective study over a 15 year period (1982-1996). Forensic Sci. Int., 1999; 103: 101-112. 7. Jovanovic J.: Occupational profile and cardiac risk: mechanisms and implications for professional drivers. Int. J. Occup. Med. Environ. Health., 1998; 11: 145-152. 8. Peters A.: Exposure to traffic and the onset of myocardial infarction. N. Engl. J. Med., 2004; 351: 1721-1730. 9. Maas R.: Syncope, driving recommendations and clinical reality: survey of patients. B.M.J., 2003; 326: 21. 10. Varga E.: Motor vehicle accident with complete loss of consciousness due to vasovagal syncope. Forensic Sci Int 2002; 130: 156-159. 11. Waclawski E.R., Gill G.V.: Diabetes mellitus and other endocrine disorders. In: Cox R.A.F., Edwards F.C., Palmer K., eds fitness for Work: The Medical Aspects, 3rd edn. Oxford: Oxford University Press 2000: 322-334. 12. Bernstein R.K.: Diabetes and driving. Diabetes Care. 2006; 29, 12: 2758. 13. Brunner G.A., et al.: Driver´s license, driving habits and traffic safety of patients with diabetes mellitus. Wien. Klin. Wochenschr. 1996; 108: 731-736. 14. Clarke W.L., et al.: To drive or not to drive: that is the decision. JAMA 1999; 282: 750-754. 15. Cox D.J., et al.: Diabetes and driving mishaps. Frequency and correlations from a multinational survey. Diabetes Care 2003; 26: 2329-2334. 16. Cundy T., Drury P.: Insulin-treated diabetes and driving in the UK. Diabetic Medicine 2003; 20: 168. 17. Distiller L.A., Kramer B.D.: Driving and diabetics on insulin. S. African. Med. J., 1996; 86: 1018-1020. 18. Flanagan D.E.H., et al.: Driving and insulin – consensus, conflict or confusion? Diabetic Medicine 2000; 17, 4: 316-320. 19. Harsch I.A., et al.: Traffic hypoglycaemias and accidents in patients with diabetes mellitus treated with different antidiabetic regimens. J. Intern. Med., 2002; 252, 4: 352-360. 20. Johnston R.V.: Metabolic and endocrine disorders. w Aviation Medicine. Ernsting J., Nicholson A.N., Rainford D.J. (red.), Butterworth-Heinemann, Oxford 1999; 303-311. 21. Kennedy R.L., et al.: Accidents in patients with insulin-treated diabetes: increased risk of low-impact falls but not motor vehicle crashes – a prospective register-based study. J. Trauma. 2002; 52, 4: 660-666. 22. MacLeod K.M., Johnston R.V.: Czy wobec chorych na cukrzycę wprowadzać ograniczenia dotyczące prowadzenia samochodu i zatrudnienia? w Cukrzyca – trudne pytania. Gill G.V., Pickup J.C., Williams G. (red.), α-medica press, Bielsko Biała 2001, 262-284. 23. Mansell P.: Diabetes and driving. Diabetic Medicine 2002; 19, 8: 617-618. 24. McGwin G., et al.: Diabetes and automobile crashes in the elderly. Diabetes Care 1999; 22: 220-227. 25. Odell M.: Assessing fitness to driver. Part 1. Aust Fam Physician 2005; 34, 5: 359. 26. Sobczyński J.: Wpływ zaburzeń przemiany materii na zdolność do kierowania pojazdami. Porównanie wyników badań glikemii na czczo u kierowców autobusów miejskich w Warszawie wg kryteriów ADA i WHO. Diabetol. Polska 1999; l6(sup 1). 27. Stevens A.B., et al.: Motor vehicle driving among diabetics taking insulin and non-diabetics. BMJ. 1989; 299, 6699: 591-595. 28. Stork A.D.M., et al.: Diabetes and Driving Desired data, research methods and their pitfalls, current knowledge, and future research Diabetes Care 2006; 29: 1942-1949. 29. Veneman T.F.: Diabetes mellitus and traffic incidents. Neth. J. Med., 1996; 48: 24-28. 30. Otto-Buczkowska E.: Problemy życiowe chorych na cukrzycę. Uprawnienia kierowcy pojazdów mechanicznych. Chory na cukrzycę w podstawowej opiece zdrowotnej. Program Edukacyjny PTD, Via Medica, Gdańsk 2002; Zeszyt 1: 16-18. 31. Cox D.J., et al.: Self-treatment of hypoglycemia while driving. Diabetes Res Clin Pract. 2001; 54, 1: 17-26. 32. Cox D., et al.: Driving mishaps and hypoglycaemia: risk and prevention. Int J Clin Pract suppl. 2001; 123: 38-42. 33. Deiss D., et al.: Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006; 29, 12: 2730-2732. 34. Garg S., et al.: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006; 29, 1: 44-50. 35. Klonoff D.C.: Continuous Glucose Monitoring. Roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231-1239. 36. Maran A., et al.: Continuous subcutaneous glucose monitoring in diabetic patients. Diabetes Care 2002; 25: 347-352. 37. Otto-Buczkowska E., Jarosz-Chobot P.: (Novel forms of insulin delivery.) Medycyna Rodzinna (Poland) 2003; 5, 25: 138-141. 38. Bloomgarden Z.T.: Treatment Issues in type 1 diabetes. Diabetes Care 2002; 25: 230-238. 39. Home P., et al.: Insulin detemir offers improved glycemic control compared with NPH insulin in people with Type 1 diabetes. A randomized clinical trial. Diabetes Care 2004; 27: 1081-1087. 40. Jarosz-Chobot P., et al.: Interesting trends of intensive insulin therapy and glicaemic monitoring development. Case Rep. Clin. Pract. Rev., 2004; 5: 222-227. 41. Vague P., et al.: Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycaemia compared to NPH insulin in patients with type 1 diabetes on basal-bolus regimen with pre-meal insulin aspart. Diabetes Care 2003; 26: 590-596. 42. Akhter J., Duckworth W.: Insulin infusion pumps: Cheaper in the long run? Drug benefit Trends 1997; 9: 23-26. 43. Pickup J., Keen H.: Continuous subcutaneous insulin infusion at 25 years. Diabetes Care 2002; 25: 593-598. 44. Rodrigues I.A., et al.: Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service. Diabet. Med. 2005; 22, 7: 842-849. 45. Weissberg-Benchell J., et al.: Insulin pump therapy. Diabetes Care 2003; 26: 1079-1086. 46. Cox D.J., et al.: Hypoglycemia preceding fatal car collisions. Diabetes Care. 2006; 29, 2: 467-468. 47. Diamond T.H., et al.: Motor vehicle accidents during episodes of hypoglycaemia – case reports and lessons to be learnt. Aust. Fam. Physician. 2005; 34, 3: 151-154. 48. Finck H., Rinnert K.: (Diabetes mellitus – fitness to drive private and commercial vehicles) MMW Fortschr Med. 2004; 146, 37: 47-50. 49. Frier B.M.: Hypoglycemia and driving performance. Diabetes Care 2000; 23, 2: 148-150. 50. Marrero D., Edelman S.: Hypoglycemia and driving performance. Diabetes Care 2000; 23, 2:146-147. 51. Linkeschova R., et al.: Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet. Med., 2002; 19, 9: 746-751. 52. Mianowska B.: Hipoglikemia w przebiegu cukrzycy typu 1. w Cukrzyca typu 1. Otto-Buczkowska E. (red.), Cornetis, Wrocław 2006: 209-219. 53. Samann A., et al.: Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia. 2005; 48, 10: 1965-1970. 54. Hill-Smith I.: Driving under the influence of insulin. Br. J. Gen. Pract., 2002; 52, 485: 1024-1025. 55. King A.: Driving while under the influence of insulin. Br. J. Gen. Pract., 2003; 53, 487: 149. 56. Weinger K, et al.: The perception of safe driving ability during hypoglycaemia in patients with type 1 diabetes mellitus. Am J Med 1999; 107: 246-253. 57. Cox D.J., et al.: Progressive hypoglycemia´s impact on driving simulation performance. Diabetes Care 2000; 23, 2: 163-170. 58. Cox D.J., et al.: Reduction of severe hypoglycemia (SH) with blood glucose awareness training (BGAT-2) (Abstract). Diabetes 1995; suppl. 1: 27A. 59. Cox D.J., et al.: Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int. J. Behav. Med., 2004; 11, 4: 212-8. 60. Kelly R., et al.: Medical restrictions to driving: the awareness of patients and doctors. Postgrad Med. J. 1999; 75: 537-539. 61. Rozwadowska A.: Polityka ochrony zdrowia w Unii Europejskiej z uwzględnieniem aspektów dotyczących osób chorych na cukrzycę. w Cukrzyca patogeneza, diagnostyka, leczenie. Otto-Buczkowska E. (red.), Borgis, Warszawa 2005: 256-263. 62. Gill G., et al.: Insulin-treated diabetes and driving in the UK. Diabetic Medicine 2002; 19, 6: 435-439. 63. Iżycki J.: Postępowanie orzecznicze u kandydatów na kierowców i kierowców chorych na cukrzycę. w Orzecznictwo lekarskie o predyspozycjach zdrowotnych do kierowania pojazdami silnikowymi i pracy na stanowisku kierowcy. Wągrowska-Koski E. (red.), Łódź 2005. 64. O´Neill S., Gill G.V.: Variation in licensing authority standards for diabetic taxi drivers in the United Kingdom. Driving and Employment Working Party of the British Diabetic Association.Occup Med (Lond). 2000; 50, 1: 19-21. 65. Mathiesen B., Borch-Jensen K.: Diabetes and accident insurance. A 3 year follow upof 7599 insured diabetic individuals. Diabetes Care 1997; 20: 1781-1784. 66. Graveling A.J., et al.: Hypoglycaemia and driving in people with insulin-treated diabetes: adherence to recommendations for avoidance. Diabet. Med. 2004; 21, 9: 1014-9.